The COVID-19 RT-PCRT est is a real-time reverse transcription polymerase chain reaction (rRT -PCR) test. The test can be run in a singleplex format (three individual assays) or multiplexed into a single reaction and amplification set up.
Novel Coronavirus (2019-nCoV) Real-time RT-PCR Kit is a real-time RT-PCR test intended for the qualitative detection of nucleic acid from the 2019-nCoV in oropharyngeal swabs and bronchoalveolar lavage fluid collected from individuals suspected of COVID-19 by their healthcare provider.
Cov-inu RT-PCR kit is a probe based Real Time PCR test designed for the qualitative de- tection of SARS-CoV-2 Coronavirus, the etiological agent of COVID-2019 and A + B Group Inuenza virus (orthomyxovirus). It is used to detect S- M2 ve NS1 genes in viral RNA.
Description of the Kit
Cov-inu RT PCR Kit is a multiplex PCR kit that is used for the simultaneous detection of COVID-19 agent SARS-COV-2 and Inuenza A and Inuenza B viruses from the same sample. Coronaviruses are a large family of viruses that cause infections in humans and other mammals (such as camels, cats, dogs, and bats). The SARS-CoV-2 virus is a new coronavirus that was identified by the World Health Organization (WHO) (1) on February 11, 2020. Inuenza is caused by three types of immunological RNA viruses (A, B and C) in the Orthomyxoviridae family. Seasonal inuenza is typically caused by three main hem- agglutinin subtypes (H1, H2, and H3) and two neuraminidase subtypes (N1 and N2). It is important that public health laboratories around the world conduct detailed surveillance to monitor the spread and impact of the pandemic H1N1 2009 virus, as well as predict future changes in virulence (4). Therefore, methods for rapid diagnosis, case detection and follow-up of this new pathogen in the human population are necessary to develop appropriate management strategies to reduce morbidity and mortality. The test works with single-stage real time reverse transcriptase polymerase chain reaction (On- eStep RT-PCR) with serum, lower respiratory tract samples (e.g. bronchoalveolar lavage, sputum, tracheal aspirate), and upper respiratory tract samples (e.g. nasopharyngeal uids, nasal swab) from individuals who demonstrate clinical criteria set for COVID-19 by WHO (2) and CDC (Center for Disease Control and Prevention) (3). This kit is an In-vitro diagnostic kit using specific primers designed for qualitative detection of genomic RNAs of SARS-CoV-2, Inuenza A and Inuenza B virus.
Novel Coronavirus (2019-nCoV) Real-time RT-PCR Kit is a real-time RT-PCR test intended for the qualitative detection of nucleic acid from the 2019-nCoV in oropharyngeal swabs and bronchoalveolar lavage fluid collected form individuals suspected of COVID-19 by their healthcare provider.
About SARS-CoV-2
Specific antibodies will be produced within days to weeks as the immune system makes immune defense against the SARS-CoV-2 infection. Total antibody detection is an aid in the diagnosis of patients with suspected SARS-CoV-2 infection in conjunction with clinical symptoms and result of other diagnostic methods. The test result should not be used as the sole basis for diagnosis and exclusion of SARS-CoV-2 infection. Total antibody may not be detected in the first few days of infection.
SARS-CoV-2 neutralizing antibody is a protective soluble protein secreted by adaptive immunizing cells after inoculation with SARS-CoV-2 vaccine or infection with SARS-CoV-2. These antibodies can specific bind with virus RNA binding domain (RBD) to block the binding of RBD with angiotensin-converting enzyme 2 (ACE2) on human cells surface, thus prevent the virus or its genetic material into the human cell and virus infection.
Benifits of the Kit
1) Room Temperature Transportation
2) Cost-Effective Shipping
The shipping is at room temperature, with no need of cold chain shipping.
3) Highly Sensitive, Highly Specific
Highly sensitive and highly specific for 2019-nCoV, reliable identification of COVID-19.
4) Environmentally Friendly
The kit needs neither bulky packaging nor cold chain shipping.
* Detection of Sars-Cov-2 with reverse transcption Real time PCR ( TAT 2.0 hr )
* Amplify N gene and RdRp(orf1ab) gene of Sars-Cov2
AVAILABLE SAMPLE TYPE
* Sputum
* Oropharyngeal ( OP ) and nasopharyngeal ( NP ) swabs
SARS COV-2 VARIANTS REAL TIME KIT 5 targets.
One single reaction tube per sample. Identification of the main SARS Cov-2 variants of concern, UK, South Africa, Brazil, Nigeria, Indian (Delta).
The KAiRA 2019-nCoV PCR Detection Kit is a one step RT-PCR reagent system, based on real-time PCR technology, for the qualitative detection and differentiation of lineage B-beta Coronavirus and severe acute respiratory syndrome coronavirus 2 specific RNA.
The test kit has FDA and CE Approval and comes in packs of 100 tests. In combination with Dr PCR the test results for PCR Testing can be given in under an hour and are compatible for use for international travel requirements.
Product Details:
Number of Reactions(Preps)/Kit : 100 Rxns Per Box
Brand : HIMEDIA
Storage Temperature : -10 to -20 C
Detection : Probe Based
Target : E, N and RdRp gene.
Cat No : MBPCR243
Description
A ready to use Rt-PCR Kit for Detection of Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causing coronavirus disease 2019 (COVID-19). SARS-CoV-2 is a coronavirus, subgenus Sarbecovirus, 150-200nm in diameter with a genome size of about 30
Used For
A ready to use Rt-PCR Kit for Detection of Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causing coronavirus disease 2019 (COVID-19).
- Store at room temperature
- Whole turnaround time, from sample collection to result analysis, can be as short as 50 minutes.
- All in one packaging: RNA extracted from a specimen can be simply loaded in premixed, aliquoted 8 strip tubes to perform PCR.
Without a need for pre-PCR preparation step, it not only reduces risks of contamination but also workload of healthcare operators.
Ezplex Respiratory Pathogens Real-time PCR Kit is an in vitro diagnostic test for the qualitative detection of 19 respiratory viruses and 6 types of pneumonia-causing bacteria through nucleic acids isolated and extracted from human throat swabs using real-time polymerase chain reaction
Comprehensive Panel- One test can identify 19 respiratory viruses and 6 bacterial species simultaneously.
Sensitivity Detection of all targeted viruses and bacteria with high sensitivity.
Convenience Genetree Viewer analysis software available for users to conveniently produce test results.
Clinical Performance: Clinical testing confirmed the high sensitivity and specificity.
Stability: Shelf life of up to 12 months.
Analytical Specificity: Testing of 31 species of microorganisms showed no cross reactivity.
